— Know what they know.
Not Investment Advice

NRIX NASDAQ

Nurix Therapeutics, Inc.
1W: -0.1% 1M: -11.0% 3M: -4.4% YTD: +27.3% 1Y: +144.6% 3Y: +176.3% 5Y: -30.0%
$22.99
-0.35 (-1.50%)
 
Weekly Expected Move ±5.2%
$21 $22 $23 $24 $25
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 34 · $2.4B mcap · 98M float · 1.87% daily turnover · Short 45% of daily vol

Supply Chain Overview

1 relationships
1
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2023-09-07
Earliest Filing
2023-09-07
Latest Filing
partner: 1

Counterparties (Filed by NRIX)

1 relationships

Companies named in NRIX's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
Seagen Inc. SGEN partner Entered into a Collaboration and License Agreement for developing targeted protein degraders and Degrader-Antibody Conju 2023-09-07 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-07-09 Earnings Release; Exhibits View
2026-06-11 Regulation FD; Other Events; Exhibits View
2026-06-08 Material Agreement; Regulation FD; Exhibits Agreement View
2026-05-15 Shareholder Vote; Exhibits View
2026-04-08 Earnings Release; Exhibits View
2026-03-06 Other Events; Financial Statements and Exhibits View
2026-01-28 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2026-01-12 Regulation FD Disclosure; Financial Statements and Exhibits View
2025-12-09 Regulation FD Disclosure; Other Events; Financial Statements and Exhibits View
2025-11-10 Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits View
2025-10-22 Other Events; Financial Statements and Exhibits View
2025-10-22 Regulation FD Disclosure; Other Events; Financial Statements and Exhibits View
2025-10-09 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-09-03 Regulation FD Disclosure; Financial Statements and Exhibits View
2025-08-22 Departure/Election of Directors; Appointment of Officers View
2025-07-09 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-06-12 Regulation FD Disclosure; Other Events; Financial Statements and Exhibits View
2025-05-19 Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits View
2025-04-08 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-03-13 Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms